SIRM 2021 – Rimini
IMS GIOTTO & GMM GROUP will attend the SIRM 2021 in Rimini - PALACONGRESSO- from Thursday 28th to Saturday 30th of October. Find us at stand C6! Looking forward to see each other...
IMS GIOTTO: Virtual Showroom
We are pleased to present IMS Giotto’s Virtual Showroom! You will be able to virtually explore all our products and have access to information through brochures, images, videos and interactive 3D...
IMS Giotto receives FDA 510(k) clearance of SMART FINDER guidance systems
As of July 2021, IMS GIOTTO has received clearance under section 510(k) of the Food, Drug and Cosmetic Act for SMART FINDER Stereotactic guidance systems. Thanks to this clearance the biopsy with GIOTTO CLASS will be possible in the USA...
SIRM Webinar on prone breast biopsy
IMS GIOTTO has supported the SIRM Foundation in its interesting webinar on Stereotactic and Tomo-guided Prone Breast Biopsy, that has seen the participation of different professionals from the field of mammography and breast...
ISO 13485 MDSAP certification
In May 2021 IMS Giotto was granted the MDSAP certification valid for markets in Australia, Canada and USA. What is the Medical Device Single Audit Program? The Medical Device Single Audit Program (MDSAP) is a program that allows the conduct of a single...
Giotto CLASS Tomosynthesis lands in China
As of March 2021, IMS GIOTTO has received the Chinese National Medical Products Administration (NMPA) certification of Giotto CLASS systems. Thanks to the NMPA certification Giotto CLASS Tomosynthesis will be available in...
IMS Giotto receives FDA 510(k) clearance of Giotto CLASS Mammography systems
As of June 2020, IMS GIOTTO has received clearance under section 510(k) of the Food, Drug and Cosmetic Act for Giotto CLASS Mammography systems. Thanks to this clearance the mammography units of the CLASS line will be available in the USA...